The report predicts that the lab-developed test market will reach a global valuation of $7.3 billion in 2028, thanks mainly to rising rates of cancer and genetic disorders and the increasing number of product launches since the start of the COVID-19 pandemic.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
